Skip to main content
. Author manuscript; available in PMC: 2024 Apr 20.
Published in final edited form as: Blood Cells Mol Dis. 2024 Jan 19;105:102824. doi: 10.1016/j.bcmd.2024.102824

Figure 2. PB HPCs in mice treated with GBT1118 or vehicle control alone or followed by plerixafor (+P).

Figure 2.

N=3 each for control and GBT1118, 5 for control+P and 6 for GBT1118+P. LSK=Lin−Sca1+ckit+; LSKF = Lin−Sca1+ckit+Flt3−.

A. LSK cells/mL B. LSKF cells/mL C. LSKF as % of Lin− cells. D. LSKF as % of CD45+ cells. E. LSKF as % of CD45+ Lin− cells.

The % CD45+ cells ranged from 60–80% per sample.